Skip to main content

WNY Asset Management, LLC

Position in NVO — Novo Nordisk A S

CIK 1803296 Williamsville, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$249,192
+$42,510 QoQ
Shares Held
5,198
-7.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#948
of 1,348 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Sep 30, 2025
CallValue
$277
CallShares
5
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WNY Asset Management, LLC holds $12,807,497 across 8 Drug Manufacturers - General names. NVO ranks #7 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
5,198 $249,192

All Filings in NVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $249,192 5,198
2026-03-31 $206,682 5,624
2025-09-30 $277 5
2025-09-30 $195,713 3,527
2024-12-31 $43,010 500
2024-12-31 $194,835 2,265
2024-09-30 $405,076 3,402
2024-06-30 $633,194 4,436
2024-03-31 $579,340 4,512
2023-12-31 $358,143 3,462
2023-09-30 $314,834 3,462
2023-06-30 $266,210 1,645
2023-03-31 $254,624 1,600
2022-12-31 $216,544 1,600